UnitedHealth Group Beheer
Beheer criteriumcontroles 3/4
De CEO UnitedHealth Group is Andrew Witty, benoemd in Feb2021, heeft een ambtstermijn van 3.75 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 23.53M, bestaande uit 6.4% salaris en 93.6% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.011% van de aandelen van het bedrijf, ter waarde $ 58.84M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3.2 jaar en 6.3 jaar.
Belangrijke informatie
Andrew Witty
Algemeen directeur
US$23.5m
Totale compensatie
| Percentage CEO-salaris | 6.4% |
| Dienstverband CEO | 3.8yrs |
| Eigendom CEO | 0.01% |
| Management gemiddelde ambtstermijn | 3.2yrs |
| Gemiddelde ambtstermijn bestuur | 6.3yrs |
Recente managementupdates
Recent updates
UnitedHealth: Expect A New Normal In CMS Funding - Maintain Buy
Oct 19UnitedHealth's Q3 Earnings Preview: A Tactical Opportunity Of Note
Oct 11UnitedHealth Group (NYSE:UNH) Eyes Growth with Goodwill Partnership Amidst Cybersecurity and Financial Challenges
Sep 18
UnitedHealth Group's Guidance Is Overly Optimistic
Sep 12Is UnitedHealth Group (NYSE:UNH) A Risky Investment?
Sep 05UnitedHealth Group Incorporated's (NYSE:UNH) Popularity With Investors Is Clear
Aug 20UnitedHealth Group: Now Is The Time To Buy This Dividend Compounder
Aug 08UnitedHealth Group (NYSE:UNH) Has Some Way To Go To Become A Multi-Bagger
Aug 05UnitedHealth: Q2 2024 Earnings Review, A Panacea For Investor's Fears
Jul 16UnitedHealth Group: The Perfect Portfolio Balancer
Jul 08I'm Sticking To My Call: UnitedHealth Is Among The Best Dividend Growers
Jun 24UnitedHealth Group's (NYSE:UNH) Shareholders Will Receive A Bigger Dividend Than Last Year
Jun 09UnitedHealth Group: A Wonderful Business At A Discounted Price
May 24Investors Appear Satisfied With UnitedHealth Group Incorporated's (NYSE:UNH) Prospects
May 09UnitedHealth Group: A Quality Compounder With A Recent Pullback
May 01Investors Can Find Comfort In UnitedHealth Group's (NYSE:UNH) Earnings Quality
Apr 23UnitedHealth Group: A Loud Sigh Of Relief In Q1'24
Apr 18These 4 Measures Indicate That UnitedHealth Group (NYSE:UNH) Is Using Debt Reasonably Well
Apr 15UnitedHealth Q1 2024 Earnings Preview: Headwinds Not Enough To Derail This Juggernaut
Apr 10The Returns At UnitedHealth Group (NYSE:UNH) Aren't Growing
Apr 02UnitedHealth: Undervalued Healthcare Stock With 'Sticky' Customers
Mar 18UnitedHealth Group: Doubling Down On This Dividend Growth Machine
Feb 16UnitedHealth: Rejoice When The Market Turns Fearful (Upgrade)
Jan 29Is UnitedHealth Group (NYSE:UNH) A Risky Investment?
Jan 15UnitedHealth Group: Preparing For Q4 Earnings
Jan 08Does UnitedHealth Group (NYSE:UNH) Deserve A Spot On Your Watchlist?
Jan 02UnitedHealth: A Dividend Grower To Consider For Your Portfolio
Dec 29Getting In Cheap On UnitedHealth Group Incorporated (NYSE:UNH) Is Unlikely
Dec 21Is There An Opportunity With UnitedHealth Group Incorporated's (NYSE:UNH) 38% Undervaluation?
Dec 09UnitedHealth: I Will Get On Board If I Get A Steep Selloff
Dec 05UnitedHealth: Our Top Long Idea For 2024
Nov 27The Returns At UnitedHealth Group (NYSE:UNH) Aren't Growing
Nov 18UnitedHealth Group: Excellent Healthcare Stock To Buy
Nov 08UnitedHealth Group: Be Prepared For The Next Buying Opportunity
Oct 24UnitedHealth Group: Market Leaders Never Come Cheap
Oct 17Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$14b |
| Jun 30 2024 | n/a | n/a | US$14b |
| Mar 31 2024 | n/a | n/a | US$15b |
| Dec 31 2023 | US$24m | US$2m | US$22b |
| Sep 30 2023 | n/a | n/a | US$22b |
| Jun 30 2023 | n/a | n/a | US$21b |
| Mar 31 2023 | n/a | n/a | US$21b |
| Dec 31 2022 | US$21m | US$2m | US$20b |
| Sep 30 2022 | n/a | n/a | US$19b |
| Jun 30 2022 | n/a | n/a | US$18b |
| Mar 31 2022 | n/a | n/a | US$17b |
| Dec 31 2021 | US$18m | US$1m | US$17b |
| Sep 30 2021 | n/a | n/a | US$15b |
| Jun 30 2021 | n/a | n/a | US$15b |
| Mar 31 2021 | n/a | n/a | US$17b |
| Dec 31 2020 | US$13m | US$419k | US$15b |
| Sep 30 2020 | n/a | n/a | US$17b |
| Jun 30 2020 | n/a | n/a | US$17b |
| Mar 31 2020 | n/a | n/a | US$14b |
| Dec 31 2019 | US$17m | US$1m | US$14b |
| Sep 30 2019 | n/a | n/a | US$13b |
| Jun 30 2019 | n/a | n/a | US$13b |
| Mar 31 2019 | n/a | n/a | US$13b |
| Dec 31 2018 | US$22m | US$613k | US$12b |
| Sep 30 2018 | n/a | n/a | US$13b |
| Jun 30 2018 | n/a | n/a | US$12b |
| Mar 31 2018 | n/a | n/a | US$11b |
| Dec 31 2017 | US$62k | n/a | US$11b |
Compensatie versus markt: De totale vergoeding ($USD 23.53M ) Andrew } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 12.73M ).
Compensatie versus inkomsten: De vergoeding van Andrew is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Andrew Witty (59 yo)
3.8yrs
Tenure
US$23,534,936
Compensatie
Sir Andrew Philip Witty has been the Chief Executive Officer and Non-Independent Director of UnitedHealth Group Incorporated since February 3, 2021 and served as its Group President since November 2019 unt...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO & Non-Independent Director | 3.8yrs | US$23.53m | 0.011% $ 58.8m | |
| President & CFO | 8.4yrs | US$16.07m | 0.019% $ 104.9m | |
| Senior Counsel & Executive VP of Governance | less than a year | US$6.42m | 0.00042% $ 2.3m | |
| Chief Executive Officer of UnitedHealthcare | no data | US$10.22m | 0.0036% $ 19.8m | |
| Senior VP & Chief Accounting Officer | 9.3yrs | geen gegevens | 0.0032% $ 17.6m | |
| Executive VP and Chief Digital & Technology Officer | 2.2yrs | geen gegevens | geen gegevens | |
| Senior Vice President of Capital Markets Communications & Investor Relations | 2.7yrs | geen gegevens | geen gegevens | |
| Executive VP | less than a year | geen gegevens | 0.00080% $ 4.5m | |
| Senior VP & Chief Communications Officer | 3.7yrs | geen gegevens | geen gegevens | |
| Director of Sales for Western Pennsylvania | no data | geen gegevens | geen gegevens | |
| Executive VP & Chief Marketing Officer | 10.8yrs | geen gegevens | geen gegevens | |
| Executive VP & Chief People Officer | 2.7yrs | geen gegevens | 0.00085% $ 4.7m |
3.2yrs
Gemiddelde duur
59yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van UNH wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.2 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO & Non-Independent Director | 3.8yrs | US$23.53m | 0.011% $ 58.8m | |
| Non-Independent Non-Executive Chairman | 24.8yrs | US$595.35k | 0.12% $ 645.4m | |
| Lead Independent Director | 17.1yrs | US$441.52k | 0.00037% $ 2.1m | |
| Independent Director | 3yrs | US$366.80k | 0.00034% $ 1.9m | |
| Independent Director | 7.8yrs | US$400.16k | 0.00038% $ 2.1m | |
| Independent Director | 6.8yrs | US$392.88k | 0.00070% $ 3.9m | |
| Independent Director | 5.8yrs | US$391.05k | geen gegevens | |
| Independent Director | 7.3yrs | US$391.05k | 0.000040% $ 222.9k | |
| Independent Director | 1.9yrs | US$351.80k | 0.000060% $ 334.3k | |
| Independent Director | less than a year | US$59.33k | geen gegevens |
6.3yrs
Gemiddelde duur
67.5yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van UNH wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.3 jaar).